The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.
Open Access
- 1 April 1976
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 57 (4) , 852-860
- https://doi.org/10.1172/JCI108361
Abstract
Three regions of the human Hageman factor molecule termed the c, d, and e regions have been defined. Division of the molecule into these three regions is based on the analysis of fragments obtained by enzymatic cleavage during fluid-phase activation. The three regions have the following properties: (a) the c region has a mol wt of 40,000, has the capacity to bind to negatively charged surfaces, and does not have detectable enzymatic activity; (b) the e region possess a mol wt of 28,000 has enzymatic activity, and does not bind to negatively charged surfaces; (c) the d region has a mol wt of 12,000, is located between the c and e fragments but has not been detected as a freely existing polypeptide, and can bind firmly to negatively charged surfaces. The preparation of antibodies specific for the c and e regions is described as well as their use in defining the electrophoretic characteristics of the cde, cd, de, c, and e polypeptide fragments of Hageman factor. Evidence is given showing that the e region, but not the c or d, is released from a negatively charged surface when bound Hageman factor is exposed to proteolytic enzymes or whole plasma and that when this occurs in the presence of normal plasma, the e fragment becomes bound to C1 esterase inhibitor.This publication has 16 references indexed in Scilit:
- Structural Changes Accompanying Enzymatic Activation of Human Hageman FactorJournal of Clinical Investigation, 1974
- ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASESThe Journal of Experimental Medicine, 1973
- PLASMA PREKALLIKREIN: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATIONThe Journal of Experimental Medicine, 1972
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1971
- A Pre-Albumin Activator of PrekallikreinThe Journal of Immunology, 1970
- Human plasma kallikrein, its activation and pathological role.1968
- Activated Human Hageman Factor (XII)*Thrombosis and Haemostasis, 1965
- Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulationThe Journal of Physiology, 1958
- [A micro-method of immuno-electrophoresis].1955
- Méthode permettant l'étude conjuguée des propriétés électrophorétiques et immunochimiques d'un mélange de protéines. Application au sérum sanguinBiochimica et Biophysica Acta, 1953